Alkeon Capital Management
CYTK icon

Alkeon Capital Management’s Cytokinetics CYTK Stock Holding History

Alkeon Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300,000
Closed -$6.5M – 166
2020
Q3 		$6.5M Buy
300,000
+50,000
+20% +$1.17M 0.01% 134
2020
Q2 		$5.89M Sell
250,000
-25,000
-9% -$469K 0.01% 130
2020
Q1 		$3.24M Buy
+275,000
New +$3.51M 0.01% 125

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Alkeon Capital Management's CYTK Position: Q4 2020 in Review

Alkeon Capital Management sold out of Cytokinetics (CYTK) in Q4 2020, closing a stake of 300,000 shares — an estimated $6.5M sold.

Alkeon Capital Management first reported a position in CYTK in Q1 2020 and held it in 3 quarters. The position peaked at $6.5M in Q3 2020. 178 funds tracked by Wall St. Rank hold CYTK as of Q4 2020.

  • Alkeon Capital Management reported no remaining Cytokinetics position as of Q4 2020 after selling out during the quarter.
  • Alkeon Capital Management sold 300,000 Cytokinetics shares in Q4 2020, an estimated $6.5M.
  • Alkeon Capital Management first reported a position in Cytokinetics in Q1 2020 and held it in 3 quarters.
  • Alkeon Capital Management's Cytokinetics position peaked at $6.5M in Q3 2020.
  • 178 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2020.

Based on Alkeon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.